Stockreport

Contineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]

Contineum Therapeutics, Inc. - Common stock  (CTNM) 
PDF -Multiple potential clinical readouts in 2025- SAN DIEGO, November 06, 2024 BUSINESS WIRE )--Contineum Therapeutics, Inc. (Nasdaq: CTNM), a clinical stage biopharmace [Read more]